111106 ⎘
ssRNA viruses negative-sense; Details; Rhabdoviridae; Vesiculovirus, e.g. vesicular stomatitis Indiana virus Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Recombinant rhabdovirus encoding for a gasdermin
#2Mutated Glycoprotein of Vesicular Stomatitis Virus
#3USE OF ENGINEERED JURONA VIRUS (JURV) AS AN ONCOLYTIC VIRUS PLATFORM FOR HUMAN CANCERS
#4Recombinant Viral Genomes and Related Compositions and Methods
#5MORRETON VIRUSES AND METHODS OF USE
#6RECOMBINANT VIRAL VECTOR AND USES THEREOF
#7Mutated Glycoprotein of Vesicular Stomatitis Virus
#8Mutated Glycoprotein of Vesicular Stomatitis Virus
#9VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#10GENETICALLY MODIFIED UNGULATE CELLS AND THEIR USES IN CANCER THERAPY
#11ONCOLYTIC VIRUS AND USE THEREOF
#12ARMED CHIMERIC ONCOLYTIC VIRUSES
#13Mutated glycoprotein of vesicular stomatitis virus
#14Mutated glycoprotein of vesicular stomatitis virus
#15RECOMBINANT ONCOLYTIC VIRUS, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF
#16Mutated glycoprotein of vesicular stomatitis virus
#17Mutated glycoprotein of vesicular stomatitis virus
#18COMPOSITIONS AND METHODS FOR ENHANCING PRODUCTION, GROWTH, SPREAD, OR ONCOLYTIC AND IMMUNOTHERAPEUTIC EFFICACY OF INTERFERON-SENSITIVE VIRUSES
#19ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS
#20ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS
#21Mutated glycoprotein of vesicular stomatitis virus
#22VESICULAR STOMATITIS VIRUSES
#23CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES
#24METHODS AND MATERIALS FOR TREATING CANCER
#25ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS
#26COMBINATION OF CHECKPOINT INHIBITORS AND AN ONCOLYTIC VIRUS FOR TREATING CANCER
#27COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES
#28Chimeric vesiculoviruses and methods of use
#29ONCOLYTIC VIRUSES AND METHODS FOR USING ONCOLYTIC VIRUSES
#30VSV CHIMERIC VECTORS
#31METHODS AND MATERIALS FOR TREATING CANCER
#32NON-REPLICATING VIRUS-DERIVED PARTICLES AND USES THEREOF
#33Materials and methods for treatment with oncolytic viruses and modified CAR T cells
#34USES AND METHODS FOR ONCOLYTIC VIRUS TARGETING OF IL-4/IL-13 AND FUSIONS THEREOF
#35VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#36ONCOLYTIC RHABDOVIRUS
#37CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
#38VACCINE COMPOSITION
#39RECOMBINANT VIRAL VECTOR AND USES THEREOF
#40Vesicular stomatitis viruses
#41Compositions and methods for enhancing production, growth, spread, or oncolytic and immunotherapeutic efficacy of interferon-sensitive viruses
#42Mutated glycoprotein of vesicular stomatitis virus
#43Replication-competent vesicular stomatitis viruses
#44Oncolytic viral delivery of therapeutic polypeptides
#45RECOMBINANT ONCOLYTIC VIRUSES FOR TREATMENT OF METASTATIC CANCERS
#46Vaccine composition
#47Vaccine composition
#48Compositions and methods for enhancing growth, spread, and oncolytic and immunotherapeutic efficacy of oncolytic RNA viruses
#49Oncolytic rhabdovirus expressing IL12
#50VSV/NDV hybrid viruses for oncolytic therapy of cancer
#51Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#52Oncolytic viral delivery of therapeutic polypeptides
#53Methods and materials for treating cancer
#54ONCOLYTIC RHABDOVIRUS
#55Compositions and methods for enhancing virus replication
#56Vesicular stomatitis viruses
#57Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#58Replication-competent vesicular stomatitis viruses
#59Oncolytic virus formulation and preparation method thereof
#60Method of Vaccination Comprising a Histone Deacetylase Inhibitor
#61PSEUDOTYPED ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
#62Exogenous tap inhibitor armed oncolytic viruses and therapeutic uses thereof
#63ONCOLYTIC RHABDOVIRUS
#64Replication-competent vesicular stomatitis viruses
#65Vesicular stomatitis viruses
#66Chimeric VSV virus compositions and methods of use thereof for treatment of cancer
#67Compositions and methods for enhancing virus replication
#68Vaccine composition
#69Recombinant VSV for the Treatment of Tumor Cells
#70Non-replicating virus-derived particles and uses thereof
#71Compositions and methods for enhancing virus efficacy
#72Replication-competent vesicular stomatitis viruses
#73Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#74Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#75Method of vaccination comprising a histone deacetylase inhibitor
#76COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATTENUATED ONCOLYTIC VIRUSES
#77Methods and materials for treating cancer
#78IMMUNIZATION TO REDUCE NEUROTOXICITY DURING TREATMENT WITH CYTOLYTIC VIRUSES
#79Compositions and methods for enhancing virus efficacy
#80Engineered synergistic oncolytic viral symbiosis
#81Oncolytic rhabdovirus
#82AMPLIFICATION OF CANCER-SPECIFIC ONCOLYTIC VIRAL INFECTION BY HISTONE DEACETYLASE INHIBITORS
#83STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY
#84Mutant viruses and uses thereof
#85TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#86Compositions and methods of use of an oncolytic vesicular stomatitis virus
#87Recombinant VSV For The Treatment of Tumor Cells
#88DISPARATE SUICIDE CARRIER CELLS FOR TUMOR TARGETING OF PROMISCUOUS ONCOLYTIC VIRUSES
#89ONCOLYTIC VIRUS
#90Mutant vesicular stomatitis viruses and uses thereof
#91Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers
#92Recombinant mutants of rhabdovirus and methods of use thereof